Leveraged Finance Fights Melanoma
2020 Save the Date
May 20, 2020 | 6:30 - 9 pm
Museum of Modern Art
18 West 54th Street
New York, NY
Add to calendar
2020 Event Chairs:
Clare Bailhé (Apollo MidCap), Brendan Dillon (UBS), Kerry Dolan (PSP Investments), Lee Grinberg (Elliott Management), George Mueller (KKR), AJ Murphy (Silver Lake), Geoff Oltmans (Silver Lake), Jeff Rowbottom (Iron Park Capital), Ian Schuman (Latham & Watkins), Cade Thompson (KKR), & Trevor Watt (Hellman & Friedman)
Spotlighted in publications like Forbes, Bloomberg and The New York Times, the Leveraged Finance Fights Melanoma (LFFM) event has become the premier gathering of professionals from the leveraged finance, private equity, and investment communities who come together to fight melanoma, the deadliest form of skin cancer. Some of the most prominent names in the industry —Carl Icahn, Mike Milken, Leon Black, Henry Kravis and Howard Marks—have been featured.
The annual event raises critical funds for melanoma research and awareness on skin cancer prevention. Founded in 2011 by Jeffrey Rowbottom of PSP Investments and Brendan Dillon of UBS—both of whom combatted melanoma— the LFFM event has raised more than $10.6 million that goes directly to research.
Advances in melanoma research supported by MRA have changed the landscape dramatically for patients, with 12 of the 14 treatment options coming to market since the event’s kick-off. These advances have created a ripple effect across the field of oncology. Drugs first approved in melanoma are now being tested in more than 30 cancers.